- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Diverticulum, Esophageal in Norway
Total 54 results
-
University Hospital, AkershusKarolinska University Hospital; Ullevaal University Hospital; Diakonhjemmet Hospital and other collaboratorsCompleted
-
St. Olavs HospitalEnrolling by invitation
-
Oslo University HospitalBristol-Myers SquibbActive, not recruitingEsophageal CancerNorway
-
Oslo University HospitalNorwegian Cancer Society; Norwegian Foundation for Health and RehabilitationTerminatedEsophageal NeoplasmNorway
-
Helse FordeNot yet recruitingGastroesophageal RefluxNorway
-
Oslo University HospitalUniversity of OsloTerminatedGastroesophageal RefluxNorway
-
Norwegian University of Science and TechnologyNorwegian Foundation for Health and RehabilitationCompleted
-
Norwegian University of Science and TechnologyFerrosan ASCompleted
-
Norwegian Department of Health and Social AffairsCompletedStomach Diseases | Esophageal Diseases | Peptic UlcerNorway
-
Lund University HospitalActive, not recruitingResectable Gastric and Gastroesophageal Junction AdenocarcinomaSweden, Norway
-
Karolinska University HospitalUnknownCancer of the Esophagus | Gastric Cardia CarcinomaNorway, Sweden
-
Karolinska University HospitalThe Swedish Research Council; University of LeipzigRecruitingEsophageal Squamous Cell CarcinomaCanada, Sweden, Norway, Ireland
-
AstraZenecaCompleted
-
European Organisation for Research and Treatment...CompletedEsophageal CancerFrance, Sweden, United Kingdom, Germany, Switzerland, Spain, Australia, Norway
-
AstraZenecaCompletedGastroesophageal RefluxSweden, United Kingdom, Germany, Canada, Denmark, Norway
-
Merck Sharp & Dohme LLCActive, not recruitingEsophageal Squamous Cell Carcinoma (ESCC)Japan, Italy, Brazil, Chile, France, Germany, Korea, Republic of, Norway, Singapore, Switzerland, Taiwan, Thailand, Turkey
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Esophageal Carcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | Stage IV Esophageal Cancer AJCC v7 | Metastatic Esophageal Squamous Cell Carcinoma | Metastatic Esophageal Adenocarcinoma | Recurrent Gastroesophageal Junction Adenocarcinoma | Recurrent Esophageal Adenocarcinoma and other conditionsUnited States
-
Merck Sharp & Dohme LLCRecruitingEsophageal Squamous Cell CarcinomaJapan, Korea, Republic of, Taiwan, China, Italy, Switzerland, Brazil, Germany, Singapore, Turkey, Thailand, Chile, Norway
-
University of Dublin, Trinity CollegeKarolinska Institutet; University of Oxford; Trinity St. James's Cancer InstituteNot yet recruitingGastric Cancer | Esophageal CancerNorway, Sweden, Ireland, Italy, Germany
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Terminated
-
University of ArkansasEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedDysphagia | Spatial NeglectUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedEsophageal CancerUnited States
-
Alliance for Clinical Trials in OncologyBristol-Myers Squibb; National Cancer Institute (NCI); Sanofi; Pfizer; Eastern Cooperative...Completed
-
AstraZenecaCompletedGastroesophageal Reflux Disease (GERD)Hungary, Romania, Norway, Belgium, France, Netherlands, Germany, Australia
-
AstraZenecaCompletedEsophagitis | Heartburn | Reflux | RegurgitationSweden, Spain, Norway, Austria, Italy
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedEsophageal Cancer | Adenocarcinoma of the Gastroesophageal JunctionUnited States
-
Calypso Biotech BVCompletedCeliac Disease | Eosinophilic EsophagitisNetherlands, Belgium, Finland, Germany, Norway
-
AstraZenecaCompletedGastroesophageal RefluxItaly, Sweden, Germany, Denmark, Finland, Norway, Netherlands, Austria, Belgium, United Kingdom, France, Iceland
-
AstraZenecaCompletedChest Pain | Gastroesophageal RefluxSweden, Germany, Denmark, Norway, Canada, Netherlands
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedGastric Cancer | Esophageal Cancer | Adenocarcinoma of the Gastroesophageal JunctionUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingClinical Stage III Gastric Cancer AJCC v8 | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage IV Gastric Cancer AJCC v8 | Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 | Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction... and other conditionsUnited States, Puerto Rico
-
XenoPort, Inc.CompletedGastroesophageal Reflux DiseaseUnited States, Canada
-
CSA Medical, Inc.TerminatedBarrett's Esophagus | Low Grade Dysplasia | High Grade DysplasiaUnited States
-
Phathom Pharmaceuticals, Inc.CompletedErosive EsophagitisUnited States, Poland, Bulgaria, United Kingdom, Czechia, Hungary
-
AstraZenecaCompletedGERD | Heartburn | Acid Reflux Disease | RegurgitationUnited States
-
Ironwood Pharmaceuticals, Inc.CompletedGastroesophageal Reflux DiseaseUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedGastric Cancer | Esophageal Cancer | Adenocarcinoma of the Gastroesophageal JunctionUnited States
-
AstraZenecaCompletedGERD With Erosive EsophagitisSweden, United States, France, Italy, United Kingdom, Germany, Denmark, Finland, Norway, Canada
-
Ironwood Pharmaceuticals, Inc.CompletedGastroesophageal Reflux Disease (GERD)United States, Canada
-
Eisai Inc.CompletedSymptomatic Gastroesophageal Reflux Disease (sGERD)United States
-
AstraZenecaCompletedGERD Without Erosive EsophagitisSweden, United States, France, Italy, United Kingdom, Germany, Denmark, Finland, Norway, Canada
-
European Organisation for Research and Treatment...Active, not recruitingMalignant Neoplasm of Stomach | Malignant Neoplasm of Cardio-esophageal Junction of Stomach | Epidermal Growth Factor Receptor (EGFR) Protein OverexpressionSpain, Korea, Republic of, Singapore, Switzerland, Germany, United Kingdom, Italy, France, Estonia, Belgium, Netherlands, Norway, Portugal
-
TakedaCompleted
-
AmgenZai Lab (China only)RecruitingGastric Cancer | Gastroesophageal Junction AdenocarcinomaCanada, Japan, United States, Korea, Republic of, China, Italy, Australia, Sweden, Spain, Taiwan, France, Belgium, Denmark, Thailand, Turkey, Czechia, Bulgaria, Brazil, Norway, Mexico, Poland, Estonia, Israel, Greece, Romania, Chile, Peru, Po... and more
-
AstraZenecaAmgenRecruitingEosinophilic EsophagitisUnited States, Czechia, Spain, China, Australia, Italy, Belgium, Finland, Norway, Japan, Brazil, Germany, Greece, Canada, Netherlands, Sweden, United Kingdom, Israel, Denmark, Austria, Slovakia, New Zealand
-
Incyte CorporationActive, not recruitingCervical Cancer | Nasopharyngeal Carcinoma | Advanced Solid Tumors | Mesothelioma | Small-cell Lung Cancer | Esophageal Squamous Cell Carcinoma | Merkel Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Anal Carcinoma | Cutaneous Squamous Cell Carcinoma | MSI-H/dMMR Tumors | PD-L1 Amplified Tumor (9p24.1) | Urothelial... and other conditionsFinland, United States, United Kingdom, Belgium, Sweden, Denmark, Norway
-
AstraZenecaTerminatedEosinophilic EsophagitisUnited States, Italy, Spain, Canada, Poland, Germany, Japan, Netherlands, France, Israel, Russian Federation, United Kingdom
-
PfizerArena is a wholly owned subsidiary of PfizerCompletedEosinophilic EsophagitisUnited States, Spain, Switzerland, Australia, Belgium, Netherlands, Canada, Germany
-
CelgeneRecruitingEosinophilic EsophagitisUnited States, Belgium, Australia, Canada, Italy, Austria, Germany, Israel, Japan, Poland, Portugal, Spain, United Kingdom, Argentina, Switzerland
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedUnresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal JunctionUnited States, Spain, Italy, Australia, Russian Federation, Taiwan, Korea, Republic of, Thailand, Canada, Turkey, Germany, Romania, United Kingdom, Hungary, Brazil, France, Japan